Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
45 hedge funds and large institutions have $134M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
25% more funds holding
Funds holding: 36 → 45 (+9)
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
9% more capital invested
Capital invested by funds: $123M → $134M (+$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$25.3M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$11.1M |
| 3 |
SCM
Sio Capital Management
New York
|
+$7.61M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$7.31M |
| 5 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
+$5.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.17M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.54M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$394K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$388K |
| 5 |
FAM
Fred Alger Management
New York
|
-$125K |
GRCL Hedge Fund Activity: Q3 2023 in Review
45 institutional investors reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q3 2023, worth a combined $134M — up 9.3% from $123M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GRCL positions and 3 closed out — a net gain of 9 holders — while 15 added to existing stakes and 13 trimmed.
The largest buyer was Vivo Capital, adding an estimated $25.3M. The largest seller was Great Point Partners, cutting an estimated $6.17M.
- 45 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q3 2023, up from 36 in Q2 2023.
- Funds reported $134M of Gracell Biotechnologies Inc. American Depositary Shares stock for Q3 2023, up 9.3% quarter-over-quarter.
- 12 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q3 2023 and 3 closed out, a net change of +9 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares buyer in Q3 2023 was Vivo Capital, an estimated $25.3M added.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q3 2023 was Great Point Partners, an estimated $6.17M sold.
Based on aggregated 13F filings for Q3 2023.